Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Early Administration of Tocilizumab in COVID-19 Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04346355
Recruitment Status : Terminated (Based on interim analysis for futility and given an enrolment rate almost nil)
First Posted : April 15, 2020
Last Update Posted : June 22, 2020
Sponsor:
Information provided by (Responsible Party):
Azienda Unità Sanitaria Locale Reggio Emilia